Cardiovascular death and disability can be reduced more than 50 percent.
D000924:Anticholesteremic Agents / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D002318:Cardiovascular Diseases / Q000453:epidemiology / Q000517:prevention & control*; D003906:Developing Countries; D004359:Drug Therapy, Combination; D006801:Humans; D012307:Risk Factors; D014944:World Health Organization
D000924:Anticholesteremic Agents; D001241:Aspirin